CTLA4 and relapsing-remitting multiple sclerosis: Alternatively, Mohammadzadeh et al. have explored the expression pattern of certain inhibitory receptors, including CTLA-4, analyzing the PBMC of RRMS patients in comparison with those of healthy controls, and they showed that the expression of CTLA-4 was decreased in RRMS patients compared with the controls [82].